Author:
Muhindo Mary K,Kakuru Abel,Jagannathan Prasanna,Talisuna Ambrose,Osilo Emmanuel,Orukan Francis,Arinaitwe Emmanuel,Tappero Jordan W,Kaharuza Frank,Kamya Moses R,Dorsey Grant
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference23 articles.
1. WHO: Guidelines for the treatment of malaria. 2010, Geneva, Switzerland: World Health Organization, Second
2. WHO: World Malaria Report 2011. 2011, Geneva, Switzerland: World Health Organization
3. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, Darapiseth S, Teja-Isavadharm P, Khemawoot P, Schaecher K: Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS One. 2011, 6: e19283-10.1371/journal.pone.0019283.
4. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056/NEJMoa0808859.
5. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM: Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis. 2010, 51: e82-e89. 10.1086/657120.